Header image
This product is not currently available
The MMRF CoMMpass Study: Insights


This is a virtual event, accessible online and over the phone. Access instructions will be provided after registration.


Join us for a FREE webinar designed to meet the educational
need of multiple myeloma patients and their caregivers.

For patients with multiple myeloma and their caregivers, the fast-growing number of treatment options can be overwhelming. The importance of staying current on new developments in myeloma research and treatment has never been greater.

Current efforts to develop new myeloma treatments focus on finding drugs that are matched as much as possible to the genetics and immune profile of each patient. A big part of this effort is the MMRF CoMMpass Study, which is following 1150 patients with newly diagnosed active myeloma over 8 years. This study collects extensive information about each patient's genetic makeup, as well as on what treatments each patient receives, how well they work, whether patients received a stem cell transplant, and much more. The goals of the CoMMpass Study are to learn which myeloma subtypes respond best to which therapies, and to use this information to better target precise treatments to each individual patient.

This webinar provides further insights from the CoMMpass Study and presents some of the key findings that myeloma patients and their caregivers may find helpful as they make future treatment decisions with their care team.

If you are unable to register online or do not receive a confirmation email after registering (don't forget to check your spam folder), please contact our Registration Desk at 866-872-5840 (international callers please dial 617-502-2061). You can also contact us by ✉ email

There is no fee for participating in this webinar. To register, please add this event to your cart and complete the required information on the checkout page.


As part of our registration process, we ask you to complete the pre-webinar evaluation below:

*Before you join us for the webinar(s), please provide us your responses to the following items.

*How much do you agree with the following statements?
(1 = Strongly disagree; 5 = Strongly agree)